These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 31112044)
41. Be spoilt for choice with radiolabelled RGD peptides: preclinical evaluation of ⁶⁸Ga-TRAP(RGD)₃. Notni J; Pohle K; Wester HJ Nucl Med Biol; 2013 Jan; 40(1):33-41. PubMed ID: 22995902 [TBL] [Abstract][Full Text] [Related]
42. Comparison of biological properties of (111)In-labeled dimeric cyclic RGD peptides. Zheng Y; Ji S; Tomaselli E; Yang Y; Liu S Nucl Med Biol; 2015 Feb; 42(2):137-45. PubMed ID: 25459111 [TBL] [Abstract][Full Text] [Related]
43. Evaluation of a Flexible NOTA-RGD Kit Solution Using Gallium-68 from Different Ebenhan T; Schoeman I; Rossouw DD; Grobler A; Marjanovic-Painter B; Wagener J; Kruger HG; Sathekge MM; Zeevaart JR Mol Imaging Biol; 2017 Jun; 19(3):469-482. PubMed ID: 27743211 [TBL] [Abstract][Full Text] [Related]
44. PET imaging of very late antigen-4 in melanoma: comparison of 68Ga- and 64Cu-labeled NODAGA and CB-TE1A1P-LLP2A conjugates. Beaino W; Anderson CJ J Nucl Med; 2014 Nov; 55(11):1856-63. PubMed ID: 25256059 [TBL] [Abstract][Full Text] [Related]
45. Evaluation of [ Jahandideh A; Ståhle M; Virta J; Li XG; Liljenbäck H; Moisio O; Knuuti J; Roivainen A; Saraste A Front Med (Lausanne); 2021; 8():783596. PubMed ID: 34977085 [TBL] [Abstract][Full Text] [Related]
46. (64)Cu- and (68)Ga-Based PET Imaging of Folate Receptor-Positive Tumors: Development and Evaluation of an Albumin-Binding NODAGA-Folate. Farkas R; Siwowska K; Ametamey SM; Schibli R; van der Meulen NP; Müller C Mol Pharm; 2016 Jun; 13(6):1979-87. PubMed ID: 27145400 [TBL] [Abstract][Full Text] [Related]
47. Comparative preclinical evaluation of Trencsényi G; Dénes N; Nagy G; Kis A; Vida A; Farkas F; Szabó JP; Kovács T; Berényi E; Garai I; Bai P; Hunyadi J; Kertész I J Pharm Biomed Anal; 2017 May; 139():54-64. PubMed ID: 28273651 [TBL] [Abstract][Full Text] [Related]
48. Imaging of bacterial infection: Harnessing positron emission tomography and Cherenkov luminescence imaging with UBI-derived octapeptide. Mitra JB; Mukherjee A; Kumar A; Chandak A; Rakshit S; Yadav HD; Pandey BN; Sarma HD Drug Dev Res; 2023 Nov; 84(7):1513-1521. PubMed ID: 37571805 [TBL] [Abstract][Full Text] [Related]
50. Fusarinine C, a novel siderophore-based bifunctional chelator for radiolabeling with Gallium-68. Zhai C; Summer D; Rangger C; Haas H; Haubner R; Decristoforo C J Labelled Comp Radiopharm; 2015 May; 58(5):209-14. PubMed ID: 25874571 [TBL] [Abstract][Full Text] [Related]
51. Comparative Evaluation of Using NOTA and DOTA Derivatives as Bifunctional Chelating Agents in the Preparation of Guleria M; Das T; Amirdhanayagam J; Sarma HD; Dash A Cancer Biother Radiopharm; 2018 Feb; 33(1):8-16. PubMed ID: 29373046 [TBL] [Abstract][Full Text] [Related]
52. Development and Evaluation of Interleukin-2-Derived Radiotracers for PET Imaging of T Cells in Mice. van der Veen EL; Suurs FV; Cleeren F; Bormans G; Elsinga PH; Hospers GAP; Lub-de Hooge MN; de Vries EGE; de Vries EFJ; Antunes IF J Nucl Med; 2020 Sep; 61(9):1355-1360. PubMed ID: 32111688 [TBL] [Abstract][Full Text] [Related]
53. Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice. Jeong JM; Hong MK; Chang YS; Lee YS; Kim YJ; Cheon GJ; Lee DS; Chung JK; Lee MC J Nucl Med; 2008 May; 49(5):830-6. PubMed ID: 18413379 [TBL] [Abstract][Full Text] [Related]
54. RGD conjugates of the H2dedpa scaffold: synthesis, labeling and imaging with 68Ga. Boros E; Ferreira CL; Yapp DT; Gill RK; Price EW; Adam MJ; Orvig C Nucl Med Biol; 2012 Aug; 39(6):785-94. PubMed ID: 22381779 [TBL] [Abstract][Full Text] [Related]
55. First-In-Human Study Demonstrating Tumor-Angiogenesis by PET/CT Imaging with (68)Ga-NODAGA-THERANOST, a High-Affinity Peptidomimetic for αvβ3 Integrin Receptor Targeting. Baum RP; Kulkarni HR; Müller D; Satz S; Danthi N; Kim YS; Brechbiel MW Cancer Biother Radiopharm; 2015 May; 30(4):152-9. PubMed ID: 25945808 [TBL] [Abstract][Full Text] [Related]
56. Radiogallium Complex-Conjugated Bifunctional Peptides for Detecting Primary Cancer and Bone Metastases Simultaneously. Ogawa K; Yu J; Ishizaki A; Yokokawa M; Kitamura M; Kitamura Y; Shiba K; Odani A Bioconjug Chem; 2015 Aug; 26(8):1561-70. PubMed ID: 26087328 [TBL] [Abstract][Full Text] [Related]
57. Prospective Phase II Trial of [ Carlsen EA; Loft M; Loft A; Czyzewska D; Andreassen M; Langer SW; Knigge U; Kjaer A J Nucl Med; 2023 Feb; 64(2):252-259. PubMed ID: 35981899 [TBL] [Abstract][Full Text] [Related]
58. Selection of the optimal macrocyclic chelators for labeling with von Witting E; Garousi J; Lindbo S; Vorobyeva A; Altai M; Oroujeni M; Mitran B; Orlova A; Hober S; Tolmachev V Eur J Pharm Biopharm; 2019 Jul; 140():109-120. PubMed ID: 31082509 [TBL] [Abstract][Full Text] [Related]
59. Gallium-68 and scandium-44 labelled radiotracers based on curcumin structure linked to bifunctional chelators: Synthesis and characterization of potential PET radiotracers. Orteca G; Sinnes JP; Rubagotti S; Iori M; Capponi PC; Piel M; Rösch F; Ferrari E; Asti M J Inorg Biochem; 2020 Mar; 204():110954. PubMed ID: 31838188 [TBL] [Abstract][Full Text] [Related]
60. Benefits of NOPO as chelator in gallium-68 peptides, exemplified by preclinical characterization of (68)Ga-NOPO-c(RGDfK). Simeček J; Notni J; Kapp TG; Kessler H; Wester HJ Mol Pharm; 2014 May; 11(5):1687-95. PubMed ID: 24669840 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]